References
- HISADA Y. Dysregulated hemostasis in acute promyelocytic leukemia. Int J Hematol. 2024;119[5]:526–31
- ÖSTERROOS A., MAIA T., ERIKSSON A., JÄDERSTEN M., LAZAREVIC V., WENNSTRÖM L., et al. A risk score based on real-world data to predict early death in acute promyelocytic leukemia. Haematologica. 2022;107[7]:1528–37.
- FONTES HMF., DE FREITAS JP., OLIVEIRA JHV., DE SOUSA MORAES ÉA., REGO EM., MELO RAM. Causes and risk factors for early death in adult patients with acute promyelocytic leukemia: a real-life experience. Hematol Transfus Cell Ther. 2024.
- CAI P., WU Q., WANG Y., YANG X., ZHANG X., CHEN S. An effective early death scoring system for predicting early death risk in de novo acute promyelocytic leukemia. Leuk Lymphoma. 2020;61(8):1989–95.
- GILL H., YUNG Y., CHU HT., AU WY., YIP PK., LEE E., et al. Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study. Blood Adv. 2021;5(14):2829–38.
- GILL H., RAGHUPATHY R., LEE CYY., YUNG Y., CHU HT., NI MY., et al. Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021. BMC Cancer. 2023;23(1):141.